Macromolecular prodrugs. XX. Factors influencing model dextranase-mediated depolymerization of dextran derivatives in vitro.

Acta pharmaceutica Nordica Pub Date : 1992-01-01
L S Nielsen, H Weibel, M Johansen, C Larsen
{"title":"Macromolecular prodrugs. XX. Factors influencing model dextranase-mediated depolymerization of dextran derivatives in vitro.","authors":"L S Nielsen,&nbsp;H Weibel,&nbsp;M Johansen,&nbsp;C Larsen","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Endo-dextranase-mediated depolymerization of dextran and dextran derivatives under various experimental conditions in vitro was determined. By a simultaneous determination of Mn and MW of dextrans treated with the enzyme in aqueous buffer, an initial increase of the polydispersity of the polysaccharide sample was observed, indicating that dextranase cleaved the dextran molecules into chains which differed significantly in length. A pH optimum of 5 for the enzyme action was found. However, in the pH range 5-8, which prevails in the colon, the initial depolymerization rates differed by a factor of less than 2. Dextranase treatment of a dextran sample resulted in a constant increase of the concentration of terminal reducing glucose residues per time unit suggesting, that the initial depolymerization reaction followed zero-order kinetics. For degrees of substitution below 12 the efficacy of dextranase fragmentation of dextran conjugates decreased almost linearly with increasing DS. The chemical nature of the attached drug did not significantly affect the depolymerization rates. Maximally depolymerized dextran derivatives were obtained by the combined action of dextranase and various alpha-glucosidases. Treatment of such solutions with: a) model esterases b) 80% plasma and c) 20% liver homogenate did not give rise to an acceleration of the initial drug regeneration, as compared to identical experiments carried out in pure buffer solution (pH 7.4 and 37 degrees C).</p>","PeriodicalId":7082,"journal":{"name":"Acta pharmaceutica Nordica","volume":"4 1","pages":"23-30"},"PeriodicalIF":0.0000,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta pharmaceutica Nordica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Endo-dextranase-mediated depolymerization of dextran and dextran derivatives under various experimental conditions in vitro was determined. By a simultaneous determination of Mn and MW of dextrans treated with the enzyme in aqueous buffer, an initial increase of the polydispersity of the polysaccharide sample was observed, indicating that dextranase cleaved the dextran molecules into chains which differed significantly in length. A pH optimum of 5 for the enzyme action was found. However, in the pH range 5-8, which prevails in the colon, the initial depolymerization rates differed by a factor of less than 2. Dextranase treatment of a dextran sample resulted in a constant increase of the concentration of terminal reducing glucose residues per time unit suggesting, that the initial depolymerization reaction followed zero-order kinetics. For degrees of substitution below 12 the efficacy of dextranase fragmentation of dextran conjugates decreased almost linearly with increasing DS. The chemical nature of the attached drug did not significantly affect the depolymerization rates. Maximally depolymerized dextran derivatives were obtained by the combined action of dextranase and various alpha-glucosidases. Treatment of such solutions with: a) model esterases b) 80% plasma and c) 20% liver homogenate did not give rise to an acceleration of the initial drug regeneration, as compared to identical experiments carried out in pure buffer solution (pH 7.4 and 37 degrees C).

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
大分子高活性化合物。XX。影响模型葡聚糖酶介导葡聚糖衍生物体外解聚的因素。
在不同的实验条件下,测定了内切葡聚糖酶介导的葡聚糖及其衍生物的体外解聚。通过同时测定经该酶处理的葡聚糖在缓冲液中的Mn和MW,观察到多糖样品的多分散性最初增加,表明葡聚糖酶将葡聚糖分子切割成长度差异显著的链。发现酶的最适pH值为5。然而,在结肠中普遍存在的pH值5-8范围内,初始解聚速率相差不到2倍。右旋糖酐样品经葡聚糖酶处理后,每单位时间内末端还原糖残基的浓度不断增加,表明初始解聚反应遵循零级动力学。当取代度低于12时,右旋糖酐缀合物的葡聚糖酶裂解效率几乎随DS的增加而线性下降。附着药物的化学性质对解聚速率没有显著影响。通过葡聚糖酶与多种α -葡萄糖苷酶的共同作用,得到了葡聚糖解聚程度最高的衍生物。与在纯缓冲溶液(pH 7.4和37℃)中进行的相同实验相比,用a)模型酯酶、b) 80%血浆和c) 20%肝脏匀浆处理这些溶液不会加速初始药物再生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Model systems in iontophoresis--transport efficacy. Furan and thiophene analogues of omeprazole. Chemical stability of insulin. 4. Mechanisms and kinetics of chemical transformations in pharmaceutical formulation. Chemical stability of insulin. 5. Isolation, characterization and identification of insulin transformation products. Relative bioavailability in man of noscapine administered in lozenges and mixture.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1